John Frederick Ek's Net Worth
$8.29 Million
Who is John Frederick Ek?
John Frederick Ek has an estimated net worth of $8.29 Million. This is based on reported shares across multiple companies, which include GenMark Diagnostics, Inc., and Akoya Biosciences, Inc..
SEC CIK
John Frederick Ek's CIK is 0001767921
Past Insider Trading and Trends
2020 was John Frederick Ek's most active year for acquiring shares with 5 total transactions. John Frederick Ek's most active month to acquire stocks was the month of January. 2020 was John Frederick Ek's most active year for disposing of shares, totalling 15 transactions. John Frederick Ek's most active month to dispose stocks was the month of January. 2023 saw John Frederick Ek paying a total of $100,000.00 for 340,000 shares, this is the most they've acquired in one year. In 2021 John Frederick Ek cashed out on 451,516 shares for a total of $5,866,565.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GenMark Diagnostics, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -232.99K |
$24.05 | -$5,603,481.65 |
0
|
Apr 22
| |||
Form 4
| -7.63% | -19.25K |
—
|
—
| 232.99K |
Feb 25
| |||
Form 4
| -0.36% | -908.00 |
—
|
—
| 252.24K |
Feb 23
| |||
Form 4
| -0.19% | -487.00 |
—
|
—
| 253.15K |
Feb 21
| |||
Form 4
| +20.63% | 43.38K |
—
|
—
| 253.64K |
Feb 18
| |||
Form 4
| +17.93% | 31.97K |
$14.24 | -$263,084.00 | 210.26K |
Jan 21 - Jan 25
| |||
Form 4
| -0.79% | -1.42K |
$13.17 | -$18,675.06 | 178.28K |
Nov 24
| |||
Form 4
| -0.90% | -1.64K |
$13.85 | -$22,672.45 | 179.7K |
Nov 19
| |||
Form 4
| -18.51% | -41.20K |
$13.82 | -$569,328.72 | 181.34K |
Scheduled
|
Sep 22
| ||
Form 4
| -2.51% | -5.72K |
$12.98 | -$74,284.54 | 222.53K |
Scheduled
|
Sep 16
| ||
Form 4
| -0.66% | -1.51K |
$14.14 | -$21,422.10 | 228.26K |
Aug 25
| |||
Form 4
| -1.12% | -2.59K |
$15.60 | -$40,431.31 | 229.77K |
Scheduled
|
Aug 20
| ||
Form 4
| -12.56% | -33.38K |
$15.98 | -$533,313.76 | 232.36K |
Scheduled
|
Aug 14 - Aug 18
| ||
Form 4
| -0.55% | -1.46K |
$9.52 | -$13,899.20 | 265.74K |
May 28
| |||
Form 4
| -0.61% | -1.65K |
$10.46 | -$17,238.08 | 267.2K |
May 19
| |||
Form 4
| -0.39% | -1.04K |
$3.51 | -$3,650.40 | 268.85K |
Feb 27
| |||
Form 4
| +63.17% | 104.48K |
$3.81 | -$1,965.96 | 269.89K |
Feb 25
| |||
Form 4
| -5.08% | -8.85K |
$3.80 | -$33,622.40 | 165.41K |
Feb 20
| |||
Form 4
| +2.03% | 3.46K |
$4.80 | -$13,214.40 | 174.25K |
Jan 21
| |||
Form 4
| -0.82% | -1.42K |
$5.43 | -$7,710.60 | 170.79K |
Nov 25
| |||
Form 4
| -0.28% | -489.00 |
$5.55 | -$2,713.95 | 172.21K |
Nov 20
| |||
Form 4
| -0.83% | -1.44K |
$6.03 | -$8,677.17 | 172.7K |
Aug 27
| |||
Form 4
| -0.29% | -510.00 |
$6.25 | -$3,187.50 | 174.14K |
Aug 20
| |||
Form 4
| -1.07% | -1.89K |
$5.87 | -$11,094.30 | 174.65K |
Aug 5
| |||
Form 4
| -0.52% | -924.00 |
$6.60 | -$6,098.40 | 176.54K |
May 30
| |||
Form 4
| -0.28% | -501.00 |
$6.85 | -$3,431.85 | 177.46K |
May 23
| |||
Form 4
| -0.28% | -495.00 |
$6.83 | -$3,380.85 | 177.96K |
May 21
| |||
Form 4
| -2.83% | -5.21K |
$6.79 | -$35,341.95 | 178.46K |
Feb 25
| |||
Form 4
| +68.10% | 74.41K |
$6.16 | -$3,665.20 | 183.66K |
Feb 18 - Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akoya Biosciences, Inc. (AKYA) Snapshot price: $5.98
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.32% | -14.27K |
$4.56 | -$65,080.32 | 180.73K |
Apr 1
| |||
Form 4
| +21.88% | 35K |
—
|
—
| 195K |
Feb 22
| |||
Form 4
|
∞
| 20K |
$5.00 | $100,000.00 | 20K |
Jun 12
| |||
Form 4
|
∞
| 160K |
—
|
—
| 160K |
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||